R A Ehrenkranz Selected Research

Deaf-Blind Disorders

1/2003	Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
1/2003	Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants.
1/2003	Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R A Ehrenkranz Research Topics

Disease

10	Lung Diseases (Lung Disease) 01/2003 - 01/2000
9	Cerebral Palsy (Spastic Diplegia) 01/2003 - 01/2000
8	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2008 - 01/2000
7	Hemorrhage 01/2003 - 01/2000
7	Hypertension (High Blood Pressure) 01/2003 - 01/2000
7	Infections 01/2003 - 01/2000
6	Necrotizing Enterocolitis 01/2003 - 01/2000
4	Birth Weight (Birth Weights) 08/2010 - 10/2001
4	Intestinal Perforation 01/2008 - 01/2001
4	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2003 - 01/2000
4	Inflammation (Inflammations) 01/2003 - 01/2000
3	Deaf-Blind Disorders 01/2003 - 01/2003
3	Glycosuria 01/2003 - 01/2000
3	Pneumothorax 01/2003 - 01/2000
2	Bronchopulmonary Dysplasia 01/2008 - 06/2007
2	Patent Ductus Arteriosus 01/2008 - 01/2003
2	Enterocolitis 01/2003 - 01/2003
2	Pulmonary Hypertension 01/2003 - 01/2000
2	Blindness (Hysterical Blindness) 01/2001 - 01/2000
1	Pre-Eclampsia (Preeclampsia) 10/2015
1	Weight Gain 08/2010
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 11/2007
1	Respiratory Insufficiency (Respiratory Failure) 06/2007
1	Periventricular Leukomalacia (Neonatal Cerebral Leukomalacia) 01/2003
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2001
1	Hemosiderosis 02/2000
1	Hyperventilation 01/2000

Drug/Important Bio-Agent (IBA)

9	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2003 - 01/2000
8	Oxygen (Dioxygen)IBA 06/2008 - 01/2000
8	SteroidsIBA 01/2003 - 01/2000
6	Dexamethasone (Maxidex)FDA LinkGeneric 01/2003 - 01/2000
2	Surface-Active Agents (Surfactants)IBA 06/2008 - 11/2007
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2007 - 01/2000
2	IronIBA 10/2001 - 02/2000
1	Folic Acid (Vitamin M)FDA LinkGeneric 10/2015
1	Proteins (Proteins, Gene)FDA Link 08/2010
1	Indomethacin (Indometacin)FDA LinkGeneric 01/2008
1	Prostaglandin Antagonists (Prostaglandin Antagonist)IBA 01/2008
1	Erythropoietin FDA Link 10/2001
1	Interleukin-6 (Interleukin 6)IBA 02/2001
1	Macrophage Colony-Stimulating FactorIBA 02/2001
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 02/2001
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2001
1	Interleukin-8 (Interleukin 8)IBA 02/2001
1	Interleukin-11 (Interleukin 11)IBA 02/2001
1	Interleukin-13IBA 02/2001
1	Inflammation MediatorsIBA 02/2001
1	Chemokine CCL5IBA 02/2001
1	Chemokine CCL3IBA 02/2001
1	Interleukin-1 (Interleukin 1)IBA 02/2001
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2001
1	AlkaliesIBA 01/2000

Therapy/Procedure

9	Therapeutics 01/2003 - 01/2000
1	Enteral Nutrition (Feeding, Tube) 08/2010
1	Retreatment 01/2008
1	Ligation 01/2008
1	Intermittent Positive-Pressure Ventilation 11/2007
1	Erythrocyte Transfusion 10/2001
1	Extracorporeal Membrane Oxygenation 01/2000